TrueBeam can treat tumors smaller than 0.5 mm, and is preferred in the treatment of tumors with small volumes in the brain and whole body and adjacent to risky organs.   

TrueBeam, which can be used in all advanced radiotherapy modalities including conventional and 3-dimensional conformal radiotherapy, as well as image-guided radiotherapy and radiosurgery (IGRT and IGRS), intensity-adjusted arc therapy (RapidArc), and stereotactic body radiotherapy (SBRT), TrueBeam provides imaging, patient positioning, motion management, and treatment.   

It is a superior device that brings together technologies such as a control system structured to synchronize the therapy dynamically.

As the dose rate can be increased eight times, TrueBeam can deliver higher doses in a shorter time thanks to its ability to make RapidArc faster, and by significantly reducing the duration and number of sessions, it has an advantage over other devices. Another advantage is that it can take very high-resolution images and make more accurate rays possible.

TrueBeam, which can be used in the treatment of all types of cancer, makes a big difference in the treatment of lung, breast, prostate, and spinal region cancers, especially thanks to synchronized movement management.   

In addition, TrueBeam can be used in the treatment of tumors in organs such as breast, lung, and liver that require respiratory monitoring, as it can be performed by monitoring respiratory movement, giving doses with increased beams.